William Ackman's Pershing Square Capital Management said it had filed a lawsuit seeking confirmation that its request to hold a special shareholder meeting of Allergan Inc would not trigger Allergan's poison pill takeover defense.Ackman, who owns nearly 10 percent of Allergan, last week filed documents with the Securities and Exchange Commission to call a shareholder meeting to elect new directors to the company's board.The Botox maker has rejected a $53 billion joint offer from Ackman and Canadian drugmaker Valeant Pharmaceuticals International .An Allergan spokeswoman failed to comment immediately.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN remained unchanged at $162.04. In the past year, the shares have traded as low as $81.33 and as high as $172.48. On average, 4635540 shares of AGN exchange hands on a given day and today's volume is recorded at 0.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX remained unchanged at $120.75. In the past year, the shares have traded as low as $81.94 and as high as $153.10. On average, 3378190 shares of VRX exchange hands on a given day and today's volume is recorded at 0.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 3.66% or $-4.98/share to $131.12. In the past year, the shares have traded as low as $83.39 and as high as $170.45. On average, 379248 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 510618.
Source
